Actively Recruiting
Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing GENEPIC
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2026-05-13
30
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the genetic factors involved in non-syndromic cleft lip and palate (NSCL/P), a condition affecting craniofacial development. Despite advances in identifying genes related to facial formation, the molecular causes of NS human clefting remain largely unknown. This trial uses whole exome sequencing (WES), a proven method effective in identifying genes responsible for related syndromes, to better understand the genetic basis of NSCL/P. Participants undergo a clinical questionnaire and provide genetic samples for analysis through high-throughput exome sequencing. The study is organized by a multidisciplinary team at a university hospital, focusing on patients precisely diagnosed with NSCL/P who are followed at this center. The main study activity is the identification of genetic factors involved in cleft conditions using WES. Participants are involved through providing clinical information and genetic samples for sequencing. Researchers analyze the genetic data alongside patient questionnaires to identify relevant genetic factors. The primary outcome is the identification of these genetic factors on the first day of participation. The study does not involve treatment and is focused on genetic research related to orofacial clefts.
CONDITIONS
Brief Title
Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subject with a non-syndromic cleft lip and/or palate (NSCL/P) or cleft lip and palate (CL/P) of unknown cause
- National health care insurance holders
You will not qualify if you...
- Subject with a cleft lip and/or palate of known cause
- Subject with a non-syndromic cleft lip and/or palate and an IRF6 mutation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants complete a clinical questionnaire and provide genetic data through exome high-throughput sequencing for analysis.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
CHU Amiens Picardie
Amiens, France, 80054
Actively Recruiting
Research Team
B
Bénédicte DEMEER, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here